Advances in Alzheimer's disease and its treatment
DOI:
https://doi.org/10.54097/xr368202Keywords:
Alzheimer’s disease; epidemiology; pathological features; causes; treatment methods.Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disease with insidious onset. In clinical practice, comprehensive dementia is characterized by memory impairment, aphasia, recognition loss, impairment of visual and spatial skills, executive dysfunction, and personality and behavioral changes. According to the statistics, the global prevalence of dementia will be as high as 24 million, and is predicted to double every 20 years until at least 2040 [1]. The etiology of Alzheimer disease remains unclear, but most people think it is result of both genetic and environmental factors. How to cure this kind of disease has become a big trouble for decades.
Downloads
References
Reitz C, Brayne C, Mayeux R. Epidemiology of Alzheimer disease. Nature Reviews Neurology, 2011, 7(3): 137-152.
Ferri C P, Prince M, Brayne C, et al. Global prevalence of dementia: a Delphi consensus study. The lancet, 2005, 366(9503): 2112-2117.
SCHELTENS P, DE STROOPER B, KIVIPELTO M, et al. Alzheimer’s disease. Lancet. 2021;397(10284):1577-1590.
Hongyu Chen, Jianhao Wang, Yiyi Li et al. Research progress of autophagy dysfunction and pathogenesis of Alzheimer's disease . Stroke and neurological diseases,2023,30(06):626-628.
Lee JH , Yang DS , Goulbourne CN , et al. Faulty autolysosome acidification in Alzheimer’s disease mouse models induces autophagic build-up of Aβ in neurons, yielding senile plaques. Nat Neurosci , 2033,25(6):688-701.
Xu Y , Propson NE , Du SQ , et al. Autophagy deficiency modulates microglial lipid homeostasis and aggravates tau pathology and spreading. Proc Natl Acad Sci USA, 2021,118(27):e2023148118
Ying LI, Meiqi Qian, Xue Qiu. New techniques for biomarkers and early diagnosis of Alzheimer's disease . Journal of Analytical Testing,2022,41(04):553-561.
HARDY J, SELKOE DJ. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science. 2002;297(5580):353-356.
KNOPMAN DS, AMIEVA H, PETERSEN RC, et al. Alzheimer disease. Nat Rev Dis Primers. 2021;7(1):33.
Barage SH, Sonawane KD. Amyloid cascade hypothesis: pathogenesis and therapeutic strategies in Alzheimer’s disease. Neuropeptides, 2015, 52: 1-18
Min Yan, Xu Wang, Xihan Guo. Research progress in familial Alzheimer's disease caused by loss-of-function mutations in presenilin 1. Journal of Zhejiang University (Medical), 2020, 49: 487-99
Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer’s disease at 25 years. EMBO Mol Med, 2016, 8: 595-608
Armstrong RA. The molecular biology of senile plaques and neurofibrillary tangles in Alzheimer’s disease. Folia Neuropathol, 2009, 47: 289-99
Hamano T, Enomoto S, Shirafuji N, et al. Autophagy and tau protein. Int J Mol Sci, 2021, 22: 7475
Liang C, Zou T, Zhang M, et al. MicroRNA-146a switches microglial phenotypes to resist the pathological processes and cognitive degradation of Alzheimer’s disease. Theranostics, 2021, 11: 4103-21
Jiang L, Dong H, Cao H, et al. Exosomes in pathogenesis, diagnosis, and treatment of Alzheimer’s disease. Med Sci Monit, 2019, 25: 3329-35
Minyan Jiang, Xu Wang, Xihan Guo. Advances in the mechanism of microglia TREM2 regulating the occurrence of Alzheimer's disease. Bioscience, 2023, 35: 1484-97
Chen Juanlin, Jiang Minyan, Wang Xu, et al.Research progress on the mechanism of telomere and telomerase disorders promoting Alzheimer's disease.Life Sciences,2024(4),1,22.
Leroi I, Voulgari A, Breitner JC, Lyketsos CG. The epidemiology of psychosis in dementia. Am J Geriatr Psychiatry 2003;11:83–91.
Thomas P, Clement JP, Hazif-Thomas C, Leger JM. Family, Alzheimer’s disease and negative symptoms. Int J Geriatr Psychiatry 2001;16:192–202.
MINARINI A, MILELLI A, TUMIATTI V, et al. Cystamine-tacrine dimer : a new multi-target-directed ligand as potential therapeutic agent for Alzheimer’s disease treatment.Neuropharmacology, 2012,62(2) :997-1003.
YANG X, CHEN Q. Efficacy of the combined use of donepezil with either quetiapine or sodium valproate in patients with Alzheimer’s disease with behavioral and psychological symptoms of dementia, and their effects on vascular endothelial growth factors. Experimental and Therapeutic Medicine, 2021,21(1):10.
Madrazo I , Kopyov O , Avila-Rodriguez MA , et al. Transplantation of human neural progenitor cells (NPC) into putamina of parkinsonian patients : a case series study , safety and efficacy four years after surgery . Cell transplant , 2019, 28: 269-285
Jing Jiang , Zhigang Li. Advances in basic research of electroacupuncture therapy for Alzheimer's disease . World Science and technology - TCM modernization ,2015,17(2):405-410.
Chen Y , Chen Z , Sun Y , Lei J , Wei G . Mechanistic insights into the inhibition and size effects of graphene oxide nanosheets on the aggregation of an amyloid-β peptide fragment. Nanoscale. 2018;10(19):8989-8997.
Mahmoudi M, Akhavan O, Ghavami M, Rezaee F, Ghiasi SM. Graphene oxide strongly inhibits amyloid beta fibrillation. Nanoscale. 2012;4(23):7322-7325..
Yang Z, Ge C, Liu J, et al. Destruction of amyloid fibrils by graphene through penetration and extraction of peptides. Nanoscale. 2015;7(44):18725-18737.
Li Q, Liu L, Zhang S, et al. Modulating aβ33-42 peptide assembly by graphene oxide. Chemistry. 2014;20(24):7236-7240.
Wang J, Cao Y, Li Q, Liu L, Dong M. Size Effect of Graphene Oxide on Modulating Amyloid Peptide Assembly. Chemistry. 2015;21(27):9632-9637.
Wang J, Zhu Z, Bortolini C, et al. Dimensionality of carbon nanomaterial impacting on the modulation of amyloid peptide assembly. Nanotechnology. 2016;27(30):304001.
Liu Y, Xu LP, Dai W, Dong H, Wen Y, Zhang X. Graphene quantum dots for the inhibition of β amyloid aggregation. Nanoscale. 2015;7(45):19060-19065.
Panpan Jing, Yang Liu, Bo Qiu et al. Research progress of lencanizumab in treatment of early Alzheimer's disease . Chinese Clinical Pharmacology and Therapeutics,2024,29(02):207-214.
Hong Tang, Fengli Zhao. Advances in the role of hydrogen sulfide targeting autophagy in Alzheimer's disease . Modern medicine and hygiene,2024,40(04):680-684.
Yihang Lv, Cui Li, Xiaoge Wang et al. Aerobic exercise improves Alzheimer's cognitive impairment through PV-positive neurons in the hippocampus. Chinese Society of Sports Science. Zhengzhou University,2023:3.
Tao Zhou, Yan Liu, Qiulian Wang, Qingquan Dou, Xukai Li, Yinping Pan, Lingzheng Meng, Tian Xue, Spirulina platensis alleviates high fat diet-induced cognitive impairment in mice via the gut-brain axis, Journal of Functional Foods, Volume 86,2021,104706,ISSN 1756-4646,.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Highlights in Science, Engineering and Technology
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
